GSK Investigational Site

Farmington, New Mexico 87401

1 studies enrolling now · 4 studies all time

What they study most

Irritable Bowel Syndrome (IBS), Irritable Colon, Multiple Myeloma, Neoplasms, Ovarian Neoplasms, Platinum Sensitive Ovarian Cancer

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM) — Recruiting now
• Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors — Running, not enrolling
• A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer — Completed
• Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy — Completed